Evaluation of a balloon dilator to augment midtrimester abortion

Area of Science:

• Reproductive Medicine
• Medical Devices
• Pharmacology

Background:

• Induced abortion often involves a two-stage process: pharmacological induction followed by cervical dilation.
• Traditional methods for cervical dilation can prolong the interval between induction and abortion, impacting patient experience and resource utilization.

Purpose of the Study:

• To evaluate the efficacy of a new balloon-type cervical dilating device (CDD) in shortening the infusion-to-abortion interval.
• To compare the effectiveness of the CDD with different inflation configurations against standard procedures.

Main Methods:

• A balloon-type cervical dilating device (CDD) with dilator and anchor balloons was used.
• The CDD was inserted after intra-amniotic infusion of prostaglandin F2alpha and hypertonic saline.
• Patients were divided into groups based on CDD usage (dilator balloon only inflated, both balloons inflated) and a control group without the device.

Main Results:

• The mean infusion-to-abortion interval was significantly shorter when only the CDD dilator balloon was inflated (14.6 +/- 2.1 hours).
• Intervals were longer in patients with both balloons inflated (23.0 +/- 1.7 hours) and in the control group (18.8 +/- 1.0 hours).

Conclusions:

• The use of a cervical dilating device with an inflated dilator balloon can effectively shorten the interval to abortion following intra-amniotic infusion.
• This suggests a potential improvement in procedural efficiency for medication-induced abortions.